Immunization against Marek's disease using a live attenuated virus.
about
Historical backgroundMarek's disease in chickens: a review with focus on immunologyVirus and host genomic, molecular, and cellular interactions during Marek's disease pathogenesis and oncogenesisMarek's disease virus and skin interactions.Modelling Marek's disease virus (MDV) infection: parameter estimates for mortality rate and infectiousnessPathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigensVirulence and attenuation of murine cytomegalovirus.EB virus in relation to tumours.Effect of in vitro adaptation of Marek's disease virus on pock induction on the chorioallantoic membrane of embryonated chicken eggs.Marek's disease virus infection induces widespread differential chromatin marks in inbred chicken lines.Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus.Detection of Marek's disease virus DNA in chicken but not in human plasma.Isolation of virus-free Herpesvirus saimiri antigen-positive plasma membrane vesicles.Gordon Memorial Lecture. Chicken neoplasia--a model for cancer research.Are observations on tumour viruses in animals applicable to man?In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus.Neoplasms, differentiations and mutations.Are viruses important in carcinogenesis?Marek's disease herpes virus: a cytomegalovirus.Augmentation of retrovirus-induced lymphoid leukosis by Marek's disease herpesviruses in White Leghorn chickens.Cytomegalovirus infection in the neonate and its prevention.Retrovirus insertion into herpesvirus in vitro and in vivo.Marek's disease virus research in the post-sequencing era: new tools for the study of gene functions and virus-host interactions.Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene.Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.Relative loss of oncogenic potency of mouse leukemia virus (Gross) after prolonged propagation in tissue culture.The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA.Evaluation of factors influencing replication of serotype 1 Marek's disease vaccines in the chicken lung.Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.Oncogenic herpesvirus infections of animals.Neoplasia--what are the prospects of immunological intervention?Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.A novel method for genome-wide profiling of dynamic host-pathogen interactions using 3' end enriched RNA-seq.Identification of Marek's disease virus nuclear antigen in latently infected lymphoblastoid cells.Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.Evaluation of factors influencing the development of late Marek's disease virus-induced immunosuppression: virus pathotype and host sex.The industrialization of farming may be driving virulence evolution.Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression.Cell-free transmission and in vivo replication of Marek's disease virus.
P2860
Q27469486-D6936921-F317-45C5-B7CA-E1AC7DFDADF8Q28074023-94C47FD5-8D55-46C6-AAC8-224D14143ECEQ28075941-6F12D032-E520-4718-9CDC-DD24EC911B4CQ33646255-2E924CC5-110C-4F3C-9B88-D849CF24AA87Q34073274-BB799B28-A372-4B09-9AE4-7F82918E44CDQ34097285-E7825A05-F22F-4F8D-8861-D0AD60E37E36Q34165999-FCBDFA59-79A8-4EA0-B20C-F048F88BADCCQ34303146-02A6DF09-AC6F-4462-B51E-CB924EC40D32Q34386069-A4B64CA5-6E83-4A06-8A84-C1B498223F0BQ34448456-6C850AFC-C1AD-4C44-840F-9DA352DEB6F2Q34478563-4A08774B-6CAB-4C7A-B4D9-6CEDE994F2E0Q35026935-0B63337D-167A-426F-B236-B0A3857AC6FEQ35065048-DA4321C8-8FD0-49B0-A521-47A8E9E455FAQ35227550-04DDC091-08A1-4D52-83BB-ECFE26AC28B6Q35665279-636D58F5-E009-4639-9F83-0C326B213E79Q35740347-B9F52C24-38AD-46F2-92DE-80A1042585F1Q35875063-251EE0DD-D266-4647-9810-9097EE2EB153Q35875067-70AAA2D1-451D-47B1-AAB5-32132B25484DQ36443758-C3E51662-BDBF-4606-9F37-760D85C44DFCQ36780457-7738EFA8-1E2F-4B85-91B7-60B02C9E26FCQ36812299-B8706D44-DEDD-4FAF-AF33-AC544E0A3008Q36814033-5886EBF9-DCF2-4B17-858E-EC6D776B54F9Q36856571-EC6BFE24-18D3-4FE7-9329-7CC74474986AQ36899801-4C7211A4-16D2-43DB-9CB0-F938178A1A2AQ36991541-5ED06797-31E7-4C4F-A768-77AEEE09C61CQ37593161-F5C46B5A-D49A-4BBF-8EC1-940156B58D48Q37676606-158CE2D8-54D2-4A27-8318-DE4D73E71202Q38432037-76A6C5B6-CE1C-4C6F-9861-4E22B5CCF5F7Q39590202-EE33F63E-9A6C-4D69-BDFE-41606608C19FQ39876730-DDD9E62A-CEA2-47DF-BDDB-0DA2F00E3F80Q39903590-9A2E7F79-C3C0-4005-AD3C-1ABB81125E16Q39933248-B1754652-5B10-485F-91EE-6F83B261623CQ40064381-0CBB2D61-06CA-4E84-A93B-63CB88F09F60Q40078949-E157650C-CB0A-4A66-BA1F-A294E8F1464FQ40129290-703DB9D3-25AC-49C0-B824-0F0747BD367FQ40135723-D5A3BC3F-C903-436D-BE7E-30572DD3885EQ40349056-45F6F1D4-DEFD-4730-AE30-99AE84031290Q40356490-BD861CB9-F5A2-42CC-9EBF-0496381B3207Q40471547-D9F0D75C-8A6E-4EAB-9DB3-BB60860AD67BQ40709390-A0DC1D42-A8F1-4975-8588-C2DD08E5712B
P2860
Immunization against Marek's disease using a live attenuated virus.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Immunization against Marek's disease using a live attenuated virus.
@en
Immunization against Marek's disease using a live attenuated virus.
@nl
type
label
Immunization against Marek's disease using a live attenuated virus.
@en
Immunization against Marek's disease using a live attenuated virus.
@nl
prefLabel
Immunization against Marek's disease using a live attenuated virus.
@en
Immunization against Marek's disease using a live attenuated virus.
@nl
P2093
P356
P1433
P1476
Immunization against Marek's disease using a live attenuated virus.
@en
P2093
P2888
P304
P356
10.1038/221744A0
P407
P577
1969-02-01T00:00:00Z
P6179
1044679625